Unlock the advantage of pragmatic trials and improve efficiency and real-world relevance to reduce risk and strengthen ...
At ESMO 2025, AstraZeneca reported that Imfinzi plus BCG therapy reduced the risk of recurrence or death by 32% in patients ...
Learn how early regulatory engagement, validated digital systems, and robust protocol design enable biotechs to run parallel ...
In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback